Intellectual property. Decision on NFkappaB patent could have broad implications for biotech.
Garber
Ken
K
D001709:Biotechnology / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D016328:NF-kappa B / Q000037:antagonists & inhibitors*; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D014481:United States
D016328:NF-kappa B